Latest / Stock Movers / Robinhood Joins S&P; Oracle Upgrades; Summit Therapeutics Plunges
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news, The.
- 0:08Speaker 2: Stock Movers Report, your roundup of companies making moves in
- 0:12Speaker 2: the stock market, harnessing the power of Bloomberg Data.
- 0:17Speaker 3: Let's take a look at some stocks on the move today.
- 0:20Speaker 2: I'm Tom Keen and Bloomberg's Lisa Matteo.
- 0:23Speaker 4: Lisa, what do you have? Yeah, you're right on that.
- 0:24Speaker 4: So we'll start with EchoStar.
- 0:26Speaker 3: SATs is a ticker, so it rows as much as
- 0:29Speaker 3: sixty four percent before the bellots pair down, kind of
- 0:32Speaker 3: a bit since then sell it more than about twenty percent.
- 0:35Speaker 3: But Elon Musk SpaceX that owns a Starlink satellite network.
- 0:38Speaker 3: He's agreed to buy wireless Spectrum from the company for
- 0:41Speaker 3: seventeen billion dollars in cash and stock. That's the reason
- 0:44Speaker 3: for the big surge. So how it benefits EchoStar Well,
- 0:48Speaker 3: EchoStar is going to use the proceeds from the deal
- 0:50Speaker 3: to retire some of its debt fund initiatives for growth.
- 0:54Speaker 3: And then what does SpaceX get out of the deal?
- 0:57Speaker 4: Right?
- 0:57Speaker 3: So SpaceX satellite operators like spaces who want to provide
- 1:00Speaker 3: direct to service mobile service from space, they usually need
- 1:03Speaker 3: to team up with at least one mobile company that
- 1:06Speaker 3: holds its ground based mobile licenses, but SpaceX they currently
- 1:09Speaker 3: have a partnership with Team Mobile. But this spectrum deal
- 1:13Speaker 3: that's going to allow it to offer its own direct
- 1:15Speaker 3: to device offerings more independently.
- 1:18Speaker 4: So that's how SpaceX is benefit from this.
- 1:22Speaker 1: I should say this is coming just a few weeks
- 1:23Speaker 1: after this announcement from AT and T back in late
- 1:26Speaker 1: August that they were going to buy a large swath
- 1:28Speaker 1: of spectrum from Ecostar as well. I think that deal
- 1:30Speaker 1: valued to twenty three billion dollars. So I guess the
- 1:33Speaker 1: big question with that one, Tom is is this going
- 1:35Speaker 1: to get regulatory approval? Charlie Ergan's been trying to offload
- 1:38Speaker 1: all of this. Today a new chapter in that story,
- 1:40Speaker 1: and again the open question is are those deals going
- 1:42Speaker 1: to get through?
- 1:43Speaker 2: I'll have to see.
- 1:43Speaker 4: And of course this goes after the pay discussion.
- 1:46Speaker 1: What forty eight hours ago of elon.
- 1:48Speaker 4: Musk Next, what do you go? Okay?
- 1:50Speaker 3: So I want to start with a few more socks
- 1:52Speaker 3: joining the S and P five hundred later this month
- 1:54Speaker 3: because their shares are seeing a boost from it. So
- 1:56Speaker 3: we have app love and their shares have been up
- 1:58Speaker 3: as much as nine percent rob Hood up as much
- 2:00Speaker 3: as eight percent, MCRE up as much as two percent.
- 2:04Speaker 3: Who will they replace, Okay, they'll replace Market Access, Caesar's Entertainment,
- 2:09Speaker 3: and Phase Energy. That'll take place on September twenty second,
- 2:13Speaker 3: And then you have Bloomberg Intelligence. They're saying that robin
- 2:15Speaker 3: Hood's addition to the S and P five hundred is
- 2:17Speaker 3: going to expand its shareholder base. But it also talks
- 2:20Speaker 3: about which industry is about how the inclusion into the
- 2:22Speaker 3: benchmark is just becoming more important for companies because it's
- 2:25Speaker 3: like a world more and more dominated by this passive
- 2:28Speaker 3: by passive investment funds. So that's kind of the points
- 2:30Speaker 3: that they make on that summit. Therapeutics, it's it's ticker
- 2:35Speaker 3: SMMT some therapeutics. Their shares have been down, yeah, more
- 2:38Speaker 3: than twenty five percent.
- 2:41Speaker 4: New data.
- 2:41Speaker 3: It's because of this closely watched lung cancer drug. It disappointed.
- 2:46Speaker 3: The drug was seen as this possible revival to the
- 2:48Speaker 3: world's top selling cancer therapy. The company released the data
- 2:52Speaker 3: right and the data showed an improving favorable trend, helping
- 2:55Speaker 3: patients from North America to Europe live longer. But analysts
- 2:58Speaker 3: started to flag some discrepant between Chinese and Western data.
- 3:03Speaker 3: So what this says it kind of dims the hopes
- 3:05Speaker 3: for the drugs first approval beyond China, and that's why
- 3:07Speaker 3: those shares are taking a hit ye down as much
- 3:09Speaker 3: as twenty five percent.
- 3:11Speaker 4: Not good for that. Some big earning news coming out tomorrow.
- 3:15Speaker 4: Oracle reports tomorrow.
- 3:17Speaker 3: Yes, ticker oh RCL be aware for it. It shares
- 3:21Speaker 3: a bit as much as three percent before the open.
- 3:25Speaker 3: Morgan Stanley analysts, they kind of raise the target on Oracle.
- 3:28Speaker 3: But what analysts are looking for tomorrow. The cloud business
- 3:31Speaker 3: has been booming, right, but they want to assess the
- 3:33Speaker 3: impact of profit metrics. So wall Stree, you'll be looking
- 3:36Speaker 3: to put more numbers around some of the big opportunities
- 3:39Speaker 3: that the company has talked about, and they want to
- 3:41Speaker 3: see if this is really going to play out because
- 3:44Speaker 3: earlier the summer they talked about you know how they
- 3:46Speaker 3: ink this cloud services agreement with an unnamed company could
- 3:49Speaker 3: add about thirty billion to its annual revenue starting in
- 3:51Speaker 3: fiscal twenty twenty eight. So they're going to take a
- 3:54Speaker 3: step back and say, Okay, is this really going to happen.
- 3:57Speaker 2: The Stock Mover's report from Blueloomberg Radio. Check back with
- 4:02Speaker 2: us throughout the day for the latest roundup of companies
- 4:04Speaker 2: making news on Wall Street and for the latest market
- 4:07Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 4:12Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 4:15Speaker 2: the Bloomberg Business app.